Join us on Saturday, May 4th, 2-4 PM, at The Studio Reno for this rare opportunity to learn from neuroscientist, Dr. Manesh Girn (UCSF), about the latest science behind psychedelics, healing and neuroplasticity! Outside the area and wish to attend? Select the Zoom registration option for a live Zoom link.
____
Psychedelics, when used with proper preparation and integration, have the power to facilitate lasting changes in our behaviour and mental health. This talk will explore the science behind these changes with a focus on the concept of neuroplasticity, which is refers to our brain’s ability to rewire itself and create new connections.
Come join Dr. Manesh Girn as he provides a guided tour through what exactly neuroplasticity is, the ways in which psychedelics affect it, and how it can be best harnessed for healing and behaviour change in the context of psychedelic-assisted psychotherapy. The discussion will be framed using concepts from the latest scientific findings and perspectives, drawing heavily on the concept of ‘self-directed neuroplasticity’. Expect to leave this workshop with an informed and practical understanding of neuroplasticity that can be applied both in your own life – with and without psychedelics - and in the context of working with others.
Dr. Manesh Girn is a postdoctoral neuroscientist specializing in psychedelic drugs at the University of California, San Francisco. Working closely with psychedelic research pioneer Dr. Robin Carhart-Harris, he conducts research on the neural mechanisms underlying the psychedelic experience and psychedelic-assisted psychotherapy. He has been lead or co-author of over 20 peer-reviewed publications to date on topics including psychedelics, the default mode network, abstract cognitive processes, and brain network organization. Manesh also runs a popular digital platform on Instagram and YouTube called "The Psychedelic Scientist”, where he disseminates the latest findings and developments in psychedelic science in a layperson friendly manner. Finally, Manesh serves as the Chief Research Officer at EntheoTech Bioscience, a pioneering Canadian bioscience company focused on psychedelic-assisted psychotherapy and multidisciplinary mental health solutions.
SPACE IS LIMITED
EARLYBIRD REGISTRATION - $30
AFTER APRIL 20 - $35
